Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Diffusion Pharmaceuticals Announces Effects In Altitude Trial

Author: Benzinga Newsdesk | June 23, 2022 06:33am
  • Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the exercise interval
     
  • Positive effects on post-exercise recovery based when comparing measurements 10 min post-exercise to measurements at the end of the exercise interval
    • TSC was safe and well-tolerated by all subjects with no serious adverse events reported

Posted In: DFFN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist